CLSI NBS04-A

Newborn Screening by Tandem Mass Spectrometry; Approved Guideline (formerly I/LA32-A), NBS04AE

Clinical and Laboratory Standards Institute,

Publisher: CLSI

File Format: PDF

$113.00$227.62

Description

This guideline serves as a reference source for the numerous activities related to operating a tandem mass spectrometry laboratory as part of public and private newborn screening programs with the goal of creating greater test accuracy, performance, and consistency among laboratories, thereby ensuring data quality that will ultimately benefit all newborns worldwide.

More CLSI standard pdf

CLSI M02-A11 and M100-S23 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Eleventh Edition & Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement

$142.00 $285.74

CLSI M100-S23

Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement

$132.00 $265.58

CLSI POCT12-A3 (R2018)

Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, Third Edition, POCT12A3E

$90.00 $180.00

CLSI QMS14-A (R2018)

Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE

$100.00 $200.00